{
  "abstract": "Background: Alkaptonuria (AKU) is a rare autosomal recessive disorder caused by mutations in the homogentisate 1,2-dioxygenase (HGD) gene, resulting in impaired degradation of tyrosine and phenylalanine and subsequent accumulation of homogentisic acid (HGA). While dark urine may be the only clinical sign in childhood, progressive HGA deposition leads to severe manifestations in adulthood, including arthritis and cardiovascular complications.\n\nCase presentation: We report the case of a 10-year-old boy in whom alkaptonuria was diagnosed early and successfully managed with Nitisinone, an inhibitor of 4-hydroxyphenylpyruvate dioxygenase that reduces HGA production.\n\nConclusion: Nitisinone represents a cornerstone of AKU management, though vigilant monitoring for hypertyrosinemia remains essential, especially in children.",
  "abstract_shown": true,
  "affiliations": [
    "Pediatric Department, Ekbatan Hospital, Jahad Square, Hamadan University of Medical Sciences, Hamadan, Iran",
    "Clinical Pharmacy Department, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"
  ],
  "article_type": "case report",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Hossein Emad Momtaz"
    },
    {
      "affs": [
        0
      ],
      "name": "Maryam Darabi",
      "orcid": "0009-0003-2779-7822"
    },
    {
      "affs": [
        1
      ],
      "name": "Nasibeh Ghalandari"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ffeye3t3weq4w.bib",
  "cited_by": 0,
  "doi": "10.1186/s12887-026-07436-8",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757063/",
  "id": "ffeye3t3weq4w",
  "issns": [
    "1471-2431"
  ],
  "landing_url": "https://doi.org/10.1186/s12887-026-07436-8",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Case Report"
    ],
    [
      "openalex",
      "1308|Metabolism and Genetic Disorders"
    ]
  ],
  "openalex": "W7203629172",
  "pdf_url": null,
  "pmcid": "PMC13757063",
  "pmid": "43021140",
  "published": "2026-08-17",
  "publisher": "BMC",
  "ris": "https://research.draconitic.com/paper/ffeye3t3weq4w.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:22:49Z",
      "native_id": "PMC13757063",
      "source": "pmc",
      "url": "https://doi.org/10.1186/s12887-026-07436-8"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:1308|Metabolism and Genetic Disorders",
      "subfield": "general"
    }
  ],
  "title": "Marked reduction of homogentisic acid with nitisinone in a child with alkaptonuria: a case report",
  "title_text": "Marked reduction of homogentisic acid with nitisinone in a child with alkaptonuria: a case report",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:22:49Z",
  "url": "https://research.draconitic.com/paper/ffeye3t3weq4w",
  "venue": "BMC Pediatrics",
  "versions": []
}